This is my last post for a while. NH is doing what ANY GOOD business person (in this case the CEO) would do. He made sure Elite had more than the ADF we all thought was a slam dunk.
Genius? yes. Prudent CEO that made sure his ass was covered? For sure YES~!
So confident was he that he stated about the ADF at the 2014 shareholder meeting. Yet he was smart enough to diversify the product portfolio away from opioids. The opioid landscape was getting sketchy. He saw it coming? I believe he did.
Purdue, Mallinkrodt, Par, Actavis, J&J..... all paying hefty fines.
For now stay away from opioids and focus on everything else.... and glad Elite has a something else other than opioids to go to.
Thank you NH. Slickster? Not hardly.... just a prudent CEO.
Market Data 
Markets 
AI
